TERN
Terns Pharmaceuticals, Inc.
Set alert
52.95 USD 0.00 0.00%
52.95 Day range 52.97
7.65 52-week range 53.19
- YTD
- +31.06%
- 1 year
- +1,797.85%
- Open
- 52.97
- Prev close
- 52.95
- Mkt cap
- 6.12B
- Vol
- 6.33M
- Avg vol
- 4.84M
- EPS
- -1.03
- P/E
- -68.77
- Div yield
- 0.00%
More statistics
- Low
- 52.95
- High
- 52.97
- Beta
- -0.38
- Inst. own
- 109.69%
- Dividend
- 0.00
Financial health
Altman Z-Score
197.94 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -39.2×
FY 2018 5y median -5.1× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 3.7×
FY 2018 5y median 1.3× FY 2025
P/FCF -45.8×
FY 2018 5y median -6.9× FY 2025
EV/EBITDA -34.1×
FY 2018 5y median -3.8× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -2.2%
FY 2018 5y median -14.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -9.6%
FY 2018 5y median -25.7% FY 2025
ROIC -10.9%
FY 2018 5y median -29.2% FY 2025
ROA -9.4%
FY 2018 5y median -24.4% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income -8.1%
FY 2018 FY 2025
EPS (diluted) 8.0%
FY 2018 FY 2025
Free Cash Flow -17.3%
FY 2018 FY 2025
Financial Health
Current Ratio 62.4×
FY 2018 5y median 24.5× FY 2025
Quick Ratio 62.4×
FY 2018 5y median 24.5× FY 2025
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 5.5×
FY 2018 5y median 1.8× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31